Gender modulates the expression of calcium-regulating proteins in pediatric atrial myocardium

Experimental Biology and Medicine

Volumn 230, Issue 11, 2005, Pages 853-859

  Pavlovic, Mladen ^a   Schaller, André ^b   Steiner, Bernhard ^b   Berdat, Pascal ^a   Carrel, Thierry ^a   Pfammatter, Jean Pierre ^a   Ammann, Roland A ^a   Gallati, Sabina ^b  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Gender; Myocardium; Pediatrc; PLB; SERCA2a

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; PHOSPHOLAMBAN; REGULATOR PROTEIN;

ARTICLE; CHILD; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; FEMALE; HEART ATRIUM MUSCLE; HEMODYNAMICS; HUMAN; HUMAN TISSUE; INFANT; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; SEX DIFFERENCE; WESTERN BLOTTING;

EID: 28944444561     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020523001110     Document Type: Article

References (50)

1. Hoffman JIE. Incidence, prevalence and inheritance of congenital heart disease. In: Moller JH, Hoffman JIE, Eds. Pediatric Cardiovascular Medicine (1st ed). Philadelphia: Churchill Livingstone, pp257-261, 2000.
2. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79:215-262, 1999.
3. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 75:434-442, 1994.
4. Schwinger RH, Munch G, Bolck B, Karczewski P, Krause EG, Erdmann E. Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol 31:479-491, 1999.
5. Koss KL, Kranias EG. Phospholamban: a prominent regulator of myocardial contractility. Circ Res 79:1059-1063, 1996.
6. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 75:401-409, 1994.
7. 2+ transport and contractility. J Mol Cell Cardiol 30:1991-2002, 1998.
8. Boknik P, Unkel C, Kirchhefer U, Kleideiter U, Klein-Wiele O, Knapp J, Linck B, Luss H, Muller FU, Schmitz W, Vahlensieck U, Zimmermann N, Jones LR, Neumann J. Regional expression of phospholamban in the human heart. Cardiovasc Res 43:67-76, 1999.
9. Arai M, Otsu K, MacLennan DH, Periasamy M. Regulation of sarcoplasmic reticulum gene expression during cardiac and skeletal muscle development. Am J Physiol 262:C614-C620, 1992.
10. Harrer JM, Haghighi K, Kim HW, Ferguson DG, Kranias EG. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart. Am J Physiol 272:H57-H66, 1997.
11. Qu Y, Boutjdir M. Gene expression of SERCA2a and L- and T-type Ca channels during human heart development. Pediatr Res 50:569-574, 2001.
12. Fabiato A, Fabiato F. Calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cells from adult human, dog, cat, rabbit, rat, and frog hearts and from fetal and new-born rat ventricles. Ann N Y Acad Sci 307:491-522, 1978.
13. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 34:264-273, 1999.
14. Leinwand LA. Sex is a potent modifier of the cardiovascular system. J Clin Invest 112:302-307, 2003.
15. Crabbe DL, Dipla K, Ambati S, Zafeiridis A, Gaughan JP, Houser SR, Margulies KB. Gender differences in post-infarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol 41:300-306, 2003.
16. Shenoy R, Klein I, Ojamaa K. Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles. Am J Physiol Heart Circ Physiol 281:H1690-H1696, 2001.
17. Sun H, Chartier D, Leblanc N, Nattel S. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 49:751-761, 2001.
18. Ausma J, Dispersyn GD, Duimel H, Thone F, Ver Donck L, Allessie MA, Borgers M. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol 32:355-364, 2000.
19. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 75:434-442, 1994.
20. Ohkusa T, Ueyama T, Yamada J, Yano M, Fujumura Y, Esato K, Matsuzaki M. Alterations in cardiac sarcoplasmic reticulum Ca2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation. J Am Coll Cardiol 34:255-263, 1999.
21. Lompré AM, Mercadier JJ, Schwartz K. Changes in gene expression during cardiac growth. Int Rev Cytol 124:137-187, 1991.
22. Brundel BJ, van Gelder IC, Henning RH, Tuinenburg AE, Deelman LE, Tieleman RG, Grandjean JG, van Gilst WH, Crijns HJ. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res 42:443-454, 1999.
23. Lai LP, Su MJ, Lin JL, Lin FY, Tsai CH, Chen YS, Huang SK, Tseng YZ, Lien WP. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 33:1231-1237, 1999.
24. Sun H, Chartier D, Leblanc N, Nattel S. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 49:751-761, 2001.
25. Movsesian MA, Karimi M, Green K, Jones LR. Ca2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing myocardium. J Clin Invest 90:653-657, 1994.
26. Schwinger RH, Bohm M, Schmidt U, Karczewski P, Bavendiek U, Flesch M, Krause EG, Erdmann E. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92:3220-3228, 1995.
27. 2+-ATPase protein levels. Circ Res 77:759-764, 1995.
28. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74:555-564, 1994.
29. Pieske B, Maier LS, Schmidt-Schweda S. Sarcoplasmic reticulum Ca2+ load in human heart failure. Basic Res Cardiol 97(Suppl 1):I63-I71, 2002.
30. Mishra S, Gupta RC, Tiwari N, Sharov VG, Sabbah HN. Molecular mechanisms of reduced sarcoplasmic reticulum Ca(2+) uptake in human failing left ventricular myocardium. J Heart Lung Transplant 21:366-373, 2002.
31. Boknik P, Unkel C, Kirchhefer U, Kleideiter U, Klein-Wiele O, Knapp J, Linck B, Luss H, Muller FU, Schmitz W, Vahlensieck U, Zimmermann N, Jones LR, Neumann J. Regional expression of phospholamban in the human heart. Cardiovasc Res 43:67-76, 1999.
32. Meyer M, Bluhm WF, He H, Post SR, Giordano FJ, Lew WY, Dillmann WH. Phospholamban-to-SERCA2 ratio controls the force-frequency relationship. Am J Physiol 276:H779-H785, 1999.
33. Qi M, Shannon TR, Euler DE, Bers DM, Samarel AM. Downregulation of sarcoplasmic reticulum Ca2+-ATPase during progression of left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 272:H2416-H2424, 1997.
34. Gay DA, Sisodia SS, Cleveland, DW. Autoregulatory control of beta-tubulin mRNA stability is linked to translational elongation. Proc Natl Acad Sci U S A 86:5763-5767, 1989.
35. Ribadeau-Dumas A, Brady M, Boateng SY, Schwartz K, Boheler KR. Sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2) gene products are regulated post-transcriptionally during rat cardiac development. Cardiovascular Res 43:426-436, 1999.
36. Favero L, Giordan M, Tarantini G, Ramondo AB, Cardaioli P, Isabella G, Chioin R, Lupia M, Razzolini R. Gender differences in left ventricular function in patients with isolated aortic stenosis. J Heart Valve Dis 12:313-318, 2003.
37. Bella JN, Palmieri V, Kitzman DW, Liu JE, Oberman A, Hunt SC, Hopkins PN, Rao DC, Arnett DK, Devereux RB. Gender difference in diastolic function in hypertension (the HyperGEN study). Am J Cardiol 89:1052-1056, 2002.
38. Gustafsson F, Torp-Pedersen C, Burchardt H, Buch P, Seibaek M, Kjoller E, Gustafsson I, Kober L, and the DIAMOND Study Group. Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. Eur Heart J 25:129-135, 2004.
39. Hogue CW, Lillie R, Hershey T, Birge S, Nassief AM, Thomas B, Freedland KE. Gender influence on cognitive function after cardiac operation. Ann Thorac Surg 76:1119-1125, 2003.
40. Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. Impact of gender on coronary bypass operative mortality Ann Thorac Surg 66:125-131, 1998.
41. Vaccarino V, Lin ZQ, Kasl SV, Mattera JA, Roumanis SA, Abramson JL, Krumholz HM. Sex differences in health status after coronary artery bypass surgery. Circulation 108:2642, 2003.
42. Zareba W, Moss AJ, Locati EH, Lehmann MH, Peterson DR, Hall WJ, Schwartz PJ, Vincent GM, Priori SG, Benhorin J, Towbin JA, Robinson JL, Andrews ML, Napolitano C, Timothy K, Zhang L, Medina A, and the International Long QT Syndrome Registry. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol 42:103-109, 2003.
43. Smith MB, Colford D, Human DG. Perinatal supraventricular tachycardia. Can J Cardiol 8:565-568, 1992.
44. Chang R-KR, Chen AY, Klitzner TS. Female sex as a risk factor for inhospital mortality among children undergoing cardiac surgery. Circulation 106:1514, 2002.
45. Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami CA, Kajstura J, Anversa P. Myocyte death in the failing human heart is gender dependent. Circ Res 85:856-866, 1999.
46. Biondi-Zoccai GG, Abate A, Bussani R, Camilot D, Giorgio FD, Marino MP, Silvestri F, Baldi F, Biasucci LM, Baldi A. Reduced post-infarction myocardial apoptosis in women: a clue to their different clinical course? Heart 91:99-101, 2005.
47. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811, 1999.
48. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 308:1583-1587, 2005.
49. McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474, 2002.
50. Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45-71, 2004.